Back to Journals » Drug Design, Development and Therapy » Volume 14

Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies

Total article views   HTML views PDF downloads Totals
7,813 Dovepress* 6,934+ 1,039 7,973
PubMed Central* 879 198 1,077
Totals 7,813 1,237 9,050
*Since 25 February 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar